Dare Bioscience | Investor Presentation Deck

Slide schematic 7/7

image 1/1 list 1/1 paragraph 3/3 source-note 1/1 title 1/1

Components 7

logo bullet paragraph paragraph paragraph source-note headline

Tools 1

list/bullet: Bayer received the right to obtain exclusive US rights to commercialize the product, following completion of the pivotal clinical trial if Bayer, in its sole discretion, pays Daré $20 million.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Highlights the validation of the product by a major industry player (Bayer) and the financial terms of the deal.